Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

BUY
$35.33 - $55.79 $4,274 - $6,750
121 Added 65.76%
305 $17,000
Q4 2022

Feb 03, 2023

BUY
$24.4 - $41.3 $2,464 - $4,171
101 Added 121.69%
184 $6,000
Q3 2022

Nov 02, 2022

BUY
$28.48 - $52.59 $2,363 - $4,364
83 New
83 $2,000
Q2 2022

Jul 18, 2022

SELL
$36.95 - $82.41 $2,217 - $4,944
-60 Closed
0 $0
Q1 2022

Apr 19, 2022

SELL
$55.7 - $145.79 $4,288 - $11,225
-77 Reduced 56.2%
60 $5,000
Q4 2021

Jan 24, 2022

BUY
$135.05 - $182.59 $1,755 - $2,373
13 Added 10.48%
137 $20,000
Q2 2021

Jul 13, 2021

BUY
$134.22 - $202.37 $3,221 - $4,856
24 Added 24.0%
124 $24,000
Q2 2020

Jul 06, 2020

BUY
$58.39 - $89.31 $5,839 - $8,931
100 New
100 $9,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.42B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.